Stock PVCT PROVECTUS BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Provectus Biopharmaceuticals, Inc.

Equities

PVCT

US74373P1084

Market Closed - OTC Markets
Other stock markets
 03:47:41 2024-05-07 pm EDT 		5-day change 1st Jan Change
0.1788 USD +1.27% Intraday chart for Provectus Biopharmaceuticals, Inc. -9.65% +86.25%
Apr. 18 Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose CI
Apr. 16 Provectus Biopharmaceuticals, Inc. Appoints Dominic Rodrigues as President CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Provectus Biopharmaceuticals, Inc. Appoints Dominic Rodrigues as President
CI
Provectus Biopharmaceuticals, Inc. Appoints Ed Pershing as Chief Executive Officer
CI
Provectus Biopharmaceuticals, Inc. Announces Management Changes
CI
Provectus Biopharmaceuticals Names Aru Narendran, MD, PhD to Scientific Advisory Board
CI
Provectus Biopharmaceuticals, Inc. Announces Board Changes
CI
Provectus Biopharmaceuticals Inc. Names Harold Schmitz to Scientific Advisory Board
CI
Provectus Names Frank Akers to Company’S Strategic Advisory Board
CI
Provectus Biopharmaceuticals, Inc. Appoints Bruce Horowitz as Chief Operating Officer
CI
Provectus Biopharmaceuticals, Inc. Announces Changes to the Company’s Board of Directors, Effective April 27, 2018
CI
Provectus Biopharmaceuticals, Inc. Reestablishes Strategic Advisory Board
CI
Provectus Biopharmaceuticals Closes Definitive Financing with PRH Group; Announces Management Changes
CI
Provectus Biopharmaceuticals, Inc. Announces Board Changes
CI
Provectus Biopharmaceuticals, Inc. Announces Financing Up to $20 Million; Announces Board Changes
CI
Peter R. Culpepper Nominates Candidates to the Board of Provectus Biopharmaceuticals
CI
Provectus Biopharmaceuticals Terminates Peter R. Culpepper as Interim CEO and COO
CI
Provectus Biopharmaceuticals, Inc. Appoints John R. Glass as Interim Chief Financial Officer
CI
Provectus Biopharmaceuticals, Inc. Announces Management Changes
CI
Provectus Biopharmaceuticals Appoints Christopher Kaplan to its Strategic Advisory Board
CI
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board
CI
Provectus Biopharmaceuticals Inc. Appoints Brendan O'Brien to Strategic Advisory Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PVCT Stock
  4. News Provectus Biopharmaceuticals, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW